⌘K

Login Start Free

Home/Filings/4/0001607062-16-000659

4//SEC Filing

GENEREX BIOTECHNOLOGY CORP 4

Accession 0001607062-16-000659

CIK 0001059784operating

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:13 PM ET

Size

5.1 KB

Accession

0001607062-16-000659

Insider Transaction Report

Form 4

Period: 2016-02-09

GENEREX BIOTECHNOLOGY CORPGNBT

FELLOWS STEPHEN

Acting CFO

Transactions

Exercise/Conversion
Common Stock Purchase Option
2016-02-09+1,667,671→ 1,667,671 total
Exercise: $0.00From: 2016-02-09Exp: 2020-10-26→ Common Stock (1,667,671 underlying)

Documents

1 file

4
fellows021216form4.xmlPrimary
FORM 4

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001059784

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 4:13 PM ET
Size: 5.1 KB

View on SEC.gov